GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
FR2459240A1
(fr)
|
1979-06-21 |
1981-01-09 |
Cm Ind |
Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
|
EP0147716A3
(de)
|
1983-12-24 |
1987-10-28 |
ANT Nachrichtentechnik GmbH |
Verfahren und Anordnung zur verschlüsselbaren Übertragung einer Nachrichten-Binärzeichenfolge mit Authentizitätsprüfung
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
US4738954A
(en)
|
1985-11-06 |
1988-04-19 |
Warner-Lambert Company |
Novel N6 -substituted-5'-oxidized adenosine analogs
|
US4873360A
(en)
|
1986-07-10 |
1989-10-10 |
Board Of Governors Of Wayne State University |
Process for the preparation of cyclopentanoids and novel intermediates produced thereby
|
IL84414A0
(en)
|
1986-11-14 |
1988-04-29 |
Ciba Geigy Ag |
N9-cyclopentyl-substituted adenine derivatives
|
US4954504A
(en)
|
1986-11-14 |
1990-09-04 |
Ciba-Geigy Corporation |
N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
|
JP2586897B2
(ja)
|
1987-03-09 |
1997-03-05 |
富士薬品工業株式会社 |
光学活性なシス−シクロペンテン−3,5−ジオ−ルモノエステルの製造法
|
US4916224A
(en)
*
|
1988-01-20 |
1990-04-10 |
Regents Of The University Of Minnesota |
Dideoxycarbocyclic nucleosides
|
ATE84302T1
(de)
|
1988-10-20 |
1993-01-15 |
Ciba Geigy Ag |
Sulfamoylphenylharnstoffe.
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
DE69123974T2
(de)
|
1990-09-25 |
1997-05-07 |
Rhone Poulenc Rorer Int |
Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
JP3192424B2
(ja)
|
1992-04-02 |
2001-07-30 |
スミスクライン・ビーチャム・コーポレイション |
アレルギーまたは炎症疾患の治療用化合物
|
MX9301942A
(es)
|
1992-04-02 |
1994-08-31 |
Smithkline Beecham Corp |
Derivados de ciclohexan-ilideno novedosos.
|
EP0633776B1
(en)
|
1992-04-02 |
2001-05-09 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
IT1254915B
(it)
|
1992-04-24 |
1995-10-11 |
Gloria Cristalli |
Derivati di adenosina ad attivita' a2 agonista
|
US5688774A
(en)
|
1993-07-13 |
1997-11-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
A3 adenosine receptor agonists
|
US5691188A
(en)
*
|
1994-02-14 |
1997-11-25 |
American Cyanamid Company |
Transformed yeast cells expressing heterologous G-protein coupled receptor
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
US6143749A
(en)
*
|
1995-06-07 |
2000-11-07 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
WO1997024327A1
(en)
|
1996-01-02 |
1997-07-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine
|
US6376472B1
(en)
|
1996-07-08 |
2002-04-23 |
Aventis Pharmaceuticals, Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
EP0991414A4
(en)
|
1997-05-09 |
2002-10-02 |
Univ Pennsylvania |
METHODS FOR REDUCING CARDIAC ISCHEMIC LESION BY ADMINISTRATION OF ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS AND RELATED COMPOSITIONS
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
YU44900A
(sh)
*
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
FR2780057B1
(fr)
|
1998-06-18 |
2002-09-13 |
Sanofi Sa |
Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
ATE246701T1
(de)
|
1998-06-23 |
2003-08-15 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivate
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813535D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813554D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
JP4369053B2
(ja)
|
1998-06-30 |
2009-11-18 |
ダウ グローバル テクノロジーズ インコーポレイティド |
ポリマーポリオール及びその製造方法
|
WO2000023457A1
(en)
|
1998-10-16 |
2000-04-27 |
Pfizer Limited |
Adenine derivatives
|
BR9917000A
(pt)
|
1998-12-31 |
2001-12-11 |
Aventis Pharm Prod Inc |
Processo para preparar derivados dedesaza-adenosina n6-substituìda
|
US7427606B2
(en)
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
KR100439357B1
(ko)
|
1999-05-04 |
2004-07-07 |
쉐링 코포레이션 |
Ccr5 길항제로서 유용한 피페리딘 유도체
|
RU2299206C9
(ru)
|
1999-05-04 |
2007-11-20 |
Шеринг Корпорейшн |
Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5
|
RU2258071C2
(ru)
*
|
1999-05-24 |
2005-08-10 |
Юниверсити Оф Вирджиния Пэйтент Фаундейшн |
Производные 2-алкиниладенозина для борьбы с воспалительной реакцией
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
US6403567B1
(en)
*
|
1999-06-22 |
2002-06-11 |
Cv Therapeutics, Inc. |
N-pyrazole A2A adenosine receptor agonists
|
US6214807B1
(en)
*
|
1999-06-22 |
2001-04-10 |
Cv Therapeutics, Inc. |
C-pyrazole 2A A receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
ATE320800T1
(de)
|
1999-08-21 |
2006-04-15 |
Altana Pharma Ag |
Synergistische kombination von roflumilast und salmeterol
|
GB9924361D0
(en)
*
|
1999-10-14 |
1999-12-15 |
Pfizer Ltd |
Purine derivatives
|
US6586413B2
(en)
|
1999-11-05 |
2003-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
GB0003960D0
(en)
*
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
MXPA02010179A
(es)
|
2000-04-27 |
2003-04-25 |
Boehringer Ingelheim Pharma |
Nuevos betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos.
|
TWI227240B
(en)
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
UA72632C2
(uk)
|
2000-06-27 |
2005-03-15 |
Лабораторіос С.А.Л.В.А.Т., С.А. |
Карбамати, похідні від арилалкіламінів
|
GB0015727D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
CO5310534A1
(es)
|
2000-08-05 |
2003-08-29 |
Glaxo Group Ltd |
Nuevos derivados de androstano anti-inflamatorios
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
PE20020719A1
(es)
|
2000-12-22 |
2002-10-11 |
Almirall Prodesfarma Ag |
Derivados de carbamato de quinuclidina como agentes antimuscarinicos m3
|
DK1353919T3
(da)
|
2000-12-28 |
2006-11-20 |
Almirall Prodesfarma Ag |
Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
|
IL156704A0
(en)
|
2001-01-16 |
2004-01-04 |
Can Fite Biopharma Ltd |
Use of an adenosine a3 receptor agonist for inhibition of viral replication
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
GB2372741A
(en)
|
2001-03-03 |
2002-09-04 |
Univ Leiden |
C2,8-Disubstituted adenosine derivatives and their different uses
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
US20040162422A1
(en)
|
2001-03-20 |
2004-08-19 |
Adrian Hall |
Chemical compounds
|
EP1370521B1
(en)
|
2001-03-22 |
2007-12-19 |
Glaxo Group Limited |
Formanilide derivatives as beta2-adrenoreceptor agonists
|
JP2002283758A
(ja)
|
2001-03-28 |
2002-10-03 |
Fuji Photo Film Co Ltd |
平版印刷版用原版
|
CZ20032958A3
(en)
|
2001-04-30 |
2004-03-17 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
EP1258247A1
(en)
|
2001-05-14 |
2002-11-20 |
Aventis Pharma Deutschland GmbH |
Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
|
EP1395604B1
(en)
|
2001-06-12 |
2008-06-25 |
Glaxo Group Limited |
Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
|
EP2327767B1
(en)
|
2001-06-21 |
2015-04-29 |
BASF Enzymes LLC |
Nitrilases
|
MXPA04002405A
(es)
|
2001-09-14 |
2004-05-31 |
Glaxo Group Limetd |
Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
|
WO2003029264A2
(en)
|
2001-10-01 |
2003-04-10 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
|
EP1438309A1
(en)
|
2001-10-17 |
2004-07-21 |
Ucb, S.A. |
Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
IL162596A0
(en)
|
2001-12-20 |
2005-11-20 |
S A L V A T Lab Sa |
1-Alkyl-1-azoniabicyclo Ä2.2.2Ü octane carbamate derivatives and their use as muscarinic receptor ntagonists
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
US7414036B2
(en)
|
2002-01-25 |
2008-08-19 |
Muscagen Limited |
Compounds useful as A3 adenosine receptor agonists
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
UA80120C2
(en)
|
2002-03-26 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetics, pharmaceutical composition based thereon
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ATE381336T1
(de)
|
2002-04-10 |
2008-01-15 |
Univ Virginia |
Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten
|
EP1496892B1
(en)
|
2002-04-11 |
2011-01-26 |
Merck Sharp & Dohme Corp. |
1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
AU2003223702A1
(en)
|
2002-04-23 |
2003-11-10 |
Vddi Pharmaceuticals |
Inhibition of platelet aggregation
|
DE60318193T2
(de)
|
2002-04-25 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Phenethanolaminderivate
|
EP1507754A1
(en)
|
2002-05-28 |
2005-02-23 |
Theravance, Inc. |
Alkoxy aryl beta-2 adrenergic receptor agonists
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
ES2282667T3
(es)
|
2002-06-25 |
2007-10-16 |
Merck Frosst Canada Ltd. |
Inhibidores de pde4 8-(biaril)quinolinas.
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
JP2005538972A
(ja)
|
2002-07-02 |
2005-12-22 |
メルク フロスト カナダ アンド カンパニー |
ジアリール置換エタンピリドンpde4阻害剤
|
BR0312575A
(pt)
|
2002-07-08 |
2005-05-03 |
Pfizer Prod Inc |
Moduladores do receptor de glicocorticóides
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
PE20050130A1
(es)
|
2002-08-09 |
2005-03-29 |
Novartis Ag |
Compuestos organicos
|
AU2003260371A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
AU2003251693A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Pyridazinone-derivatives as pde4 inhibitors
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
ATE360627T1
(de)
|
2002-08-10 |
2007-05-15 |
Altana Pharma Ag |
Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren
|
EP1537086A2
(en)
|
2002-08-17 |
2005-06-08 |
ALTANA Pharma AG |
Novel phenanthridines
|
US20060113968A1
(en)
|
2002-08-17 |
2006-06-01 |
Altana Pharma Ag |
Novel benzonaphthyridines
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
WO2004018429A2
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
JP2006501236A
(ja)
|
2002-08-23 |
2006-01-12 |
ランバクシー ラボラトリーズ リミテッド |
ムスカリン性レセプター拮抗薬としてのフルオロおよびスルホニルアミノ含有3,6−二置換アザビシクロ(3.1.0)ヘキサン誘導体
|
CN1678306A
(zh)
|
2002-08-29 |
2005-10-05 |
贝林格尔·英格海姆药物公司 |
在炎性、变应性和增生性疾病中用作糖皮质激素模拟物的3-(磺酰氨基乙基)-吲哚衍生物
|
US7329676B2
(en)
|
2002-08-29 |
2008-02-12 |
Nycomed Gmbh |
2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
|
CA2496459C
(en)
|
2002-08-29 |
2013-06-25 |
Altana Pharma Ag |
3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
EP1541574A4
(en)
|
2002-09-18 |
2007-06-20 |
Ono Pharmaceutical Co |
TRIAZASPIRO DERIVATIVES 5.5 | UNDECANS AND DRUGS CONTAINING THEM AS AN ACTIVE INGREDIENT
|
EP1542996A4
(en)
|
2002-09-20 |
2009-11-18 |
Merck & Co Inc |
OCTAHYDRO-2H-NAPHTOc1,2-F INDOL-4-CARBONSUUREAMIDE DERIVATIVES AS SELECTIVE MODULATORS OF THE GLUCOCORTICOID RECEPTOR
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
WO2004032921A1
(en)
|
2002-10-11 |
2004-04-22 |
Pfizer Limited |
Indole derivatives as beta-2 agonists
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
WO2004037807A2
(en)
|
2002-10-22 |
2004-05-06 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
JP2006506379A
(ja)
|
2002-10-23 |
2006-02-23 |
グレンマーク・ファーマシューティカルズ・リミテッド |
炎症性およびアレルギー性疾患の治療に有用な新規三環式化合物:その調製方法およびそれらを含む医薬組成物
|
ES2302956T3
(es)
|
2002-10-28 |
2008-08-01 |
Glaxo Group Limited |
Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias.
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AU2004207482B2
(en)
|
2003-01-21 |
2009-10-08 |
Merck Sharp & Dohme Corp. |
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
JP4767842B2
(ja)
|
2003-04-01 |
2011-09-07 |
セラヴァンス, インコーポレーテッド |
β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
|
PL1613315T3
(pl)
|
2003-04-04 |
2009-07-31 |
Novartis Ag |
Pochodne chinolino-2-onu do leczenia chorób dróg oddechowych
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
WO2004106333A1
(en)
|
2003-05-28 |
2004-12-09 |
Theravance, Inc. |
Azabicycloalkane compounds as muscarinic receptor antagonists
|
EP1633714B1
(en)
|
2003-06-04 |
2008-01-23 |
Pfizer Limited |
2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
WO2005003150A2
(en)
|
2003-07-02 |
2005-01-13 |
Emory University |
Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury
|
DE10332239B3
(de)
|
2003-07-16 |
2005-03-03 |
Framatome Anp Gmbh |
Zirkoniumlegierung und Bauteile für den Kern von leichtwassergekühlten Kernreaktoren
|
WO2005033121A2
(en)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
|
GB0323701D0
(en)
|
2003-10-09 |
2003-11-12 |
Glaxo Group Ltd |
Formulations
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US7648625B2
(en)
|
2003-12-19 |
2010-01-19 |
Shell Oil Company |
Systems, methods, and catalysts for producing a crude product
|
PL1699459T3
(pl)
|
2003-12-29 |
2007-12-31 |
Can Fite Biopharma Ltd |
Sposób leczenia stwardnienia rozsianego
|
DE102004001413A1
(de)
|
2004-01-09 |
2005-08-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
TW200531692A
(en)
|
2004-01-12 |
2005-10-01 |
Theravance Inc |
Aryl aniline derivatives as β2 adrenergic receptor agonists
|
UA84048C2
(ru)
|
2004-01-22 |
2008-09-10 |
Пфайзер Инк. |
Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе
|
JP4036343B2
(ja)
|
2004-01-22 |
2008-01-23 |
ファイザー・インク |
疾患の治療のためのスルフォンアミド誘導体
|
US7320990B2
(en)
|
2004-02-13 |
2008-01-22 |
Theravance, Inc. |
Crystalline form of a biphenyl compound
|
WO2005077361A1
(de)
|
2004-02-14 |
2005-08-25 |
Boehringer Ingelheim International Gmbh |
Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
|
BRPI0508488A
(pt)
*
|
2004-03-05 |
2007-07-31 |
Cambridge Biotechnology Ltd |
compostos terapêuticos
|
US7396825B2
(en)
|
2004-05-03 |
2008-07-08 |
University Of Virginia Patent Foundation |
Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
|
PE20060272A1
(es)
|
2004-05-24 |
2006-05-22 |
Glaxo Group Ltd |
(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
|
US7825102B2
(en)
|
2004-07-28 |
2010-11-02 |
Can-Fite Biopharma Ltd. |
Treatment of dry eye conditions
|
DK1778239T3
(da)
|
2004-07-28 |
2013-12-02 |
Can Fite Biopharma Ltd |
Adenosin-a3-receptor-agonister til behandling af sygdomme forbundet medtørre øjne, herunder sjögrens syndrom
|
WO2006031505A1
(en)
|
2004-09-09 |
2006-03-23 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Purine derivatives as a3 and a1 adenosine receptor agonists
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
US20080051364A1
(en)
|
2004-11-08 |
2008-02-28 |
Pninna Fishman |
Therapeutic Treatment of Accelerated Bone Resorption
|
GB0500785D0
(en)
|
2005-01-14 |
2005-02-23 |
Novartis Ag |
Organic compounds
|
CA2596424C
(en)
|
2005-02-04 |
2016-03-29 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of e1 activating enzymes
|
GB0505219D0
(en)
*
|
2005-03-14 |
2005-04-20 |
Novartis Ag |
Organic compounds
|
GB0514809D0
(en)
*
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
CN101330909B
(zh)
|
2005-11-30 |
2012-09-26 |
坎-菲特生物药物有限公司 |
A3腺苷受体激动剂在制备治疗骨关节炎的药物中的应用
|
WO2007089507A1
(en)
|
2006-01-26 |
2007-08-09 |
The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services |
A3 adenosine receptor allosteric modulators
|
WO2007092213A2
(en)
|
2006-02-02 |
2007-08-16 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of e1 activating enzyme
|
WO2007092936A2
(en)
*
|
2006-02-08 |
2007-08-16 |
University Of Virginia Patent Foundation |
Method to treat gastric lesions
|
GB0607951D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607945D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607953D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607954D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
US8258141B2
(en)
|
2006-04-21 |
2012-09-04 |
Novartis Ag |
Organic compounds
|
GB0607944D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607948D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607950D0
(en)
*
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
EP1889846A1
(en)
|
2006-07-13 |
2008-02-20 |
Novartis AG |
Purine derivatives as A2a agonists
|
US8008307B2
(en)
|
2006-08-08 |
2011-08-30 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
|
EP1903044A1
(en)
*
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Adenosine Derivatives as A2A Receptor Agonists
|
KR20090087054A
(ko)
|
2006-11-10 |
2009-08-14 |
노파르티스 아게 |
시클로펜텐 디올 모노아세테이트 유도체
|
WO2008124150A1
(en)
*
|
2007-04-09 |
2008-10-16 |
University Of Virginia Patent Foundation |
Method of treating enteritis, intestinal damage, and diarrhea from c. difficile with an a2a adenosine receptor agonist
|
US20080262001A1
(en)
*
|
2007-04-23 |
2008-10-23 |
Adenosine Therapeutics, Llc |
Agonists of a2a adenosine receptors for treating recurrent tumor growth in the liver following resection
|
EP2170401A1
(en)
*
|
2007-06-29 |
2010-04-07 |
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services |
Dendrimer conjugates of agonists and antagonists of the gpcr superfamily
|
US20090181934A1
(en)
|
2007-10-17 |
2009-07-16 |
Novartis Ag |
Organic Compounds
|
WO2009050199A1
(en)
*
|
2007-10-17 |
2009-04-23 |
Novartis Ag |
Purine derivatives as adenosine al receptor ligands
|
US8183225B2
(en)
*
|
2007-11-08 |
2012-05-22 |
New York University |
Inhibition of bone resorption using medical implants containing adenosine receptor antagonists
|
CA2711495A1
(en)
*
|
2008-01-09 |
2009-07-16 |
Pgxhealth Llc |
Intrathecal treatment of neuropathic pain with a2ar agonists
|